Changxiang Li
Yang Liu
Jian Liu
Xiaoyu Xu5*- 1College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
- 2Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MA, United States
- 3Department of Neuroscience, School of Medicine, Johns Hopkins University, Baltimore, MA, United States
- 4Peking University Health Science Center, Beijing, China
- 5College of Traditional Chinese Medicine, Southwest University, Chongqing, China
Editorial on the Research Topic
Targeting neuron-non-neuronal interactions at the neurovascular unit in stroke and neurodegenerative disease models
Introduction
Stroke and neurodegenerative diseases continue to be major global contributors to mortality and disability (Pak et al., 2023; Walker et al., 2023). Regrettably, current treatment fall short in addressing post-stroke and neurodegenerative diseases in relation to nervous system recovery. Over the past decades, a wealth of studies (Chang et al., 2016; AlRuwaili et al., 2023; Siddiqui and Bhatt, 2023) have highlighted the potential of neuroprotective and neurorestorative therapies to mitigate brain damage after stroke and neurodegenerative diseases by promoting structural and functional recovery. Most of these therapeutic agents target a single event in the injury cascade and a single neural cell type (Ricciarelli and Fedele, 2017). However, experimental strategies that focus exclusively on vascular or neural targets have not yielded effective therapies in clinics settings. The concept of neurovascular unit (NVU) as a comprehensive target for stroke and neurodegenerative disease treatment has therefore gained traction (Alvarez et al., 2013). The NVU, with its emphasis on multicellular and cell-to-cell interactions, has emerged as a key target in cerebrovascular disease treatment (Wang et al., 2021). Stroke and neurodegenerative diseases can destroy NVU, causing both the structural and functional damage (Alvarez et al., 2023). Non-neuronal cells such as glial cells (astrocytes, microglia, and oligodendrocyte), infiltrating and resident immune cells, and vascular system components (endothelial cells, and pericytes) also play a crucial role in neuronal recovery, with complex signaling cascades that demand further investigation (Lénárt et al., 2023; Ragupathy et al., 2023).
Despite these advances, our understanding of how those cells interact during the healing process, and the mechanisms these interactions trigger that may be beneficial or detrimental to neuroprotection and nervous system regeneration, remains limited. Thus, it is imperative to approach stroke and neurodegenerative diseases with novel mechanistic studies and multifaceted, multi-target neuroprotective and neurorestorative strategies.
The aim of this Research Topic was to explore the treatment and innovative mechanisms of stroke and neurodegenerative diseases, focusing on the interactions between neurons and non-neuronal cells (astrocytes, microglia, oligodendrocytes, pericytes, endothelial cells, monocyte/macrophages, T cells, NK cells, etc.). A total of five papers were included in our Research Topic, including three original articles and two reviews.
Neurovascular unit
Stroke and neurodegenerative diseases can cause structural and functional damage to the NVU (Li et al., 2020). Each cell type within the NVU plays a vital role, either in the transmission and processing of neural signals or in maintaining the microenvironment necessary for healthy neural function (Li et al., 2019). Therefore, a comprehensive characterization of NVU structure and function is crucial to understanding the pathology of stroke and neurodegenerative diseases. In vitro NVU culture models recapitulate brain-specific functions and offer greater experimental control over the cellular and molecular interactions under investigation than in vivo models (Uwamori et al., 2017). Moreover, the exploration of multi-targeted brain cytoprotective agents has emerged as a crucial direction for future treatment of stroke and neurodegenerative diseases.
In this Research Topic, a review by Novorolsky et al. potentially illuminates a promising therapeutic avenue for ischemic or hemorrhagic stroke. Their previous investigations have validated the roles of the mitochondrial Ca2+ uniporter complex (MCUcx) and the sodium/Ca2+/lithium exchanger (NCLX) in mediating the uptake and efflux of mitochondrial Ca2+ in the brain. The review highlights the potential of nanoparticle-based approaches to enhance clinical safety and efficacy by optimizing drug delivery to diseased NVUs and limiting drug exposure in healthy brain and peripheral tissues. Furthermore, in a vitro experiment, Zhang et al. established induced pluripotent stem cell (iPSC) models from Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) patients and evaluated the blood brain barrier (BBB) function by measuring transendothelial electrical resistance (TEER). Their study demonstrates the importance of neurovascular interaction and BBB function at the molecular and cellular levels for CADASIL.
Neuron-non-neuronal interractions
Stroke and neurodegenerative diseases may lead to the destruction of all brain cell types, disrupting the relative balance among them (Shabir et al., 2018; Le Roy et al., 2021). Unfortunately, a large proportion of studies aiming to develop neuroprotective agents only target neurons, neglecting their interactions with other brain cells types and thus failing to reflect the in vivo brain characteristics (Li et al., 2021). Non-neuronal cells, including glial cells (astrocytes, microglia, and oligodendrocyte), infiltrating and resident immune cells, and the vascular system (endothelial cells, and pericytes), possess critical specific signals and execution cascades that can promote neuronal recovery (Venkat et al., 2018). Consequently, the development of neuroprotective agents should aim to protect a variety of cell types and coordinate their interactions, rather than focusing solely on neurons.
In this Research Topic, Charlton et al. suggest that brain-derived neurotrophic factor (BDNF) exerts direct anti-inflammatory effects on microglia. They discovered that BDNF treatment significantly reversed the release of both IL-6 and TNF- in primary cortical microglia following LPS-induced inflammation. This led to the hypothesis that BDNF may directly modulate microglia state, thereby influencing microglia-neuron interactions. Yuan et al. provided a comprehensive overview of the ceramide synthesis pathways and highlighted their dysregulation in stroke, cerebral small vessel disease (CSVD), and related risk factors, focusing on the underlying mechanism in different types of stroke and CSVD. They demonstrated that NVU exhibits intricate contact in a coordinated manner to control the blood-brain barrier (BBB), regulate cerebral perfusion, and maintain microenvironment homeostasis. When ischemia and hypoxia were stimulated, astrocytes were induced by two different phenotypes known as A1 and A2. Feng et al. demonstrated that 2,3,5,6-Tetramethylpyrazine (TMP) can treat ischemic stroke via the FGF2/PI3K/AKT pathway, with the astrocyte transformation into the anti-inflammatory A2 subtype playing an important role in NVU preservation and neurovascular remodeling after ischemic stroke.
Conclusion
This Research Topic encompasses five articles that cover a broad range of neuron-non-neuronal interactions at the NVU in stroke and neurodegenerative diseases. Several potential therapeutic targets for these conditions were identified, including BDNF, MCUcx, NCLX, and ceramide. TMP was highlighted as a promising candidate for the treatment of ischemic stroke. A more complex in vitro NVU system was established to better mimic the cerebral vasculature and to explore pathological mechanisms. These discoveries significantly advance our understanding of the potential molecular mechanisms and therapeutic effects in stroke and neurodegenerative diseases.
Author contributions
CL: Writing – original draft, Writing – review & editing. YL: Writing – original draft, Writing – review & editing. JL: Writing – original draft, Writing – review & editing. XX: Writing – original draft, Writing – review & editing.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants from the National Natural Science Foundation of China (NSFC, 82104560) of CL.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
AlRuwaili, R., Al-Kuraishy, H. M., Alruwaili, M., Khalifa, A. K., Alexiou, A., Papadakis, M., et al. (2023). The potential therapeutic effect of phosphodiesterase 5 inhibitors in the acute ischemic stroke (AIS). Mol. Cell Biochem. doi: 10.1007/s11010-023-04793-1
Alvarez, J. I., Katayama, T., and Prat, A. (2013). Glial influence on the blood brain barrier. Glia 61, 1939–1958. doi: 10.1002/glia.22575
Alvarez, M. M., Salazar, F. E., Rodriguez, T., D'Egidio, F., Borlongan, C. V., and Lee, J. Y. (2023). Endogenous extracellular vesicles participate in brain remodeling after ischemic stroke. Int. J. Mol. Sci. 24, 6857. doi: 10.3390/ijms242316857
Chang, J., Yao, X., Zou, H., Wang, L., Lu, Y., Zhang, Q., et al. (2016). BDNF/PI3K/Akt and Nogo-A/RhoA/ROCK signaling pathways contribute to neurorestorative effect of Houshiheisan against cerebral ischemia injury in rats. J. Ethnopharmacol. 194, 1032–1042. doi: 10.1016/j.jep.2016.11.005
Le Roy, L., Letondor, A., Le Roux, C., Amara, A., and Timsit, S. (2021). Cellular and molecular mechanisms of R/S-roscovitine and CDKs related inhibition under both focal and global cerebral ischemia: a focus on neurovascular unit and immune cells. Cells 10, 104. doi: 10.3390/cells10010104
Lénárt, N., Cserép, C., Császár, E., Pósfai, B., and Dénes, Á. (2023). Microglia-neuron-vascular interactions in ischemia. Glia. doi: 10.1002/glia.24487. [Epub ahead of print].
Li, C., Sui, C., Wang, W., Yan, J., Deng, N., Du, X., et al. (2021). Baicalin attenuates oxygen-glucose deprivation/reoxygenation-induced injury by modulating the BDNF-TrkB/PI3K/Akt and MAPK/Erk1/2 signaling axes in neuron-astrocyte cocultures. Front. Pharmacol. 12, 599543. doi: 10.3389/fphar.2021.599543
Li, C., Wang, X., Yan, J., Cheng, F., Ma, X., Chen, C., et al. (2020). Cholic acid protects in vitro neurovascular units against oxygen and glucose deprivation-induced injury through the BDNF-TrkB signaling pathway. Oxid. Med. Cell Longev. 2020, 1201624. doi: 10.1155/2020/1201624
Li, C. X., Wang, X. Q., Cheng, F. F., Yan, X., Luo, J., and Wang, Q. G. (2019). Hyodeoxycholic acid protects the neurovascular unit against oxygen-glucose deprivation and reoxygenation-induced injury in vitro. Neural Regen. Res. 14, 1941–1949. doi: 10.4103/1673-5374.259617
Pak, M. E., Kim, Y. J., Kim, H., Shin, C. S., Yoon, J. W., Jeon, S. M., et al. (2023). Anti-neuroinflammatory effects of the human milk oligosaccharide, 2′-fucosyllactose, exerted via modulation of M2 microglial activation in a mouse model of ischemia-reperfusion injury. Antioxidants (Basel) 12, 1281. doi: 10.3390/antiox12061281
Ragupathy, H., Vukku, M., and Barodia, S. K. (2023). Cell-type-specific mitochondrial quality control in the brain: a plausible mechanism of neurodegeneration. Int. J. Mol. Sci. 24, 4421. doi: 10.3390/ijms241914421
Ricciarelli, R., and Fedele, E. (2017). The amyloid cascade hypothesis in alzheimer's disease: it's time to change our mind. Curr. Neuropharmacol. 15, 926–935. doi: 10.2174/1570159X15666170116143743
Shabir, O., Berwick, J., and Francis, S. E. (2018). Neurovascular dysfunction in vascular dementia, Alzheimer's and atherosclerosis. BMC Neurosci. 19, 62. doi: 10.1186/s12868-018-0465-5
Siddiqui, T., and Bhatt, L. K. (2023). Targeting sigma-1 receptor: a promising strategy in the treatment of Parkinson's disease. Neurochem. Res. 48, 2925–2935. doi: 10.1007/s11064-023-03960-6
Uwamori, H., Higuchi, T., Arai, K., and Sudo, R. (2017). Integration of neurogenesis and angiogenesis models for constructing a neurovascular tissue. Sci. Rep. 7, 17349. doi: 10.1038/s41598-017-17411-0
Venkat, P., Shen, Y., Chopp, M., and Chen, J. (2018). Cell-based and pharmacological neurorestorative therapies for ischemic stroke. Neuropharmacology. 134, 310–322. doi: 10.1016/j.neuropharm.2017.08.036
Walker, A. C., Bhargava, R., Bucher, M., Brust, A. S., and Czy, D. M. (2023). Identification of proteotoxic and proteoprotective bacteria that non-specifically affect proteins associated with neurodegenerative diseases. bioRxiv [Preprint]. doi: 10.1101/2023.10.24.563685
Keywords: stroke, neurodegenerative disease, neuron-non-neuronal cells interactions, neurovascular unit, treatment, mechanisms
Citation: Li C, Liu Y, Liu J and Xu X (2024) Editorial: Targeting neuron-non-neuronal interactions at the neurovascular unit in stroke and neurodegenerative disease models. Front. Cell. Neurosci. 18:1353281. doi: 10.3389/fncel.2024.1353281
Received: 10 December 2023; Accepted: 12 January 2024;
Published: 26 January 2024.
Edited and reviewed by: Dirk M. Hermann, University of Duisburg-Essen, Germany
Copyright © 2024 Li, Liu, Liu and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Changxiang Li, changxiang1202@163.com; Yang Liu, liuyang19870210@outlook.com; Jian Liu, liujianpku@bjmu.edu.cn; Xiaoyu Xu, xxy0618@xinan.com